Question: is mayzent approved in canada?
Answer: (Novartis) is pleased to announce that Health Canada has approved MayzentTM (siponimod) for the treatment of adults with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features characteristic of multiple sclerosis inflammatory activity, to delay the progression of ...